Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Urinary Bladder Neoplasms
×
Ado-Trastuzumab Emtansine
×
Gastrointestinal
×
Clear all
Filters
3
NCT02999672
2019-08-28
KAMELEON
Hoffmann-La Roche
Phase 2
Completed
20 enrolled
14 charts